Research News and Research

RSS

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Drug trafficking and use are fueling the spread of HIV/AIDS in Kenya, according to a recent report by the U.N. Security Council, the Nation reports. "A statement from the council's Presidency currently … states that Afghan heroin was being imported, causing a dramatic increase in heroin addiction and spreading HIV/AIDS in the slums of Nairobi and Mombasa, Kenya's two main cities," the newspaper writes.

15 Dec 2009

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Genocea Biosciences, a leading vaccine discovery and development company, today announced it has been awarded a grant from the University of Pittsburgh Medical Center’s (UPMC) Sexually Transmitted Infections (STI) Cooperative Research Center for the development of vaccines for Chlamydia trachomatis.

15 Dec 2009

Almac Discovery initiates Phase I clinical trial of intranasal Granisetron for CINV

Almac Discovery today announced the start of Phase I clinical trial of the novel intranasal Granisetron product. This product, which uses Archimedes' proprietary ChiSys® delivery technology, is being developed as a rapidly acting, well tolerated and convenient treatment for chemotherapy-induced nausea and vomiting (CINV).

15 Dec 2009

Prescription drug import amendment divides Senate Democrats

The Senate is battling over a proposed amendment that would allow prescription drugs to be imported from other countries where prices are lower.

15 Dec 2009

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software. LAB TRACKER(TM) HIV is a full-service, scalable software platform designed to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS.

15 Dec 2009

University of Wisconsin IRB approves GenSpera's G-202 Phase I study for cancer

GenSpera, Inc. announced today that the Institutional Review Board (IRB) at the University of Wisconsin, in Madison, WI, has approved a Phase I study of its target activated pro-drug, G-202, for the treatment of cancer. The FDA (US Food and Drug Administration) approved the study in September. GenSpera expects to enroll the first study patient early in the first quarter of 2010.

15 Dec 2009

Encouraging results from DAVANAT in combination with chemotherapies and biologics

Pro-Pharmaceuticals, Inc. today announced that the Brussels Branch of the Ludwig Institute of Cancer Research is testing the ability of DAVANAT® to stop Galectin-3 from blocking the immune system’s action on cancer cells. Peer reviewed studies have demonstrated that Galectin-1 and Galectin-3 induce apoptosis (cell death) in immune system T cells (“Galectins,” Chapter 7, Wiley, 2008).

15 Dec 2009

Celgene announces positive data from its apremilast Phase IIb study for plaque-type psoriasis

Celgene Corporation announced clinical data from an investigational Phase IIb, double-blind, placebo-controlled study of apremilast (CC-10004) in patients with moderate-to-severe plaque-type psoriasis (PSOR-005). This was a 352-patient, multi-center study in which patients received either 10mg, 20mg or 30mg of apremilast twice per day (BID), or placebo.

15 Dec 2009

Interpersonal Psychotherapy may hold hope for teenager girls at risk of obesity

A team of scientists at the Uniformed Services University of the Health Sciences and the National Institutes of Health have piloted psychotherapy treatment to prevent excessive weight gain in teenager girls deemed 'at risk' for obesity.

15 Dec 2009

Cellular and subcellular effects of PACE technology presented

SANUWAVE Health, Inc., (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, announced that the cellular and subcellular effects of PACE™ technology were described during a lecture presented this past weekend.

15 Dec 2009

Lytix Biopharma AS receives approval to commence Phase I clinical trials of Oncopore

The Norwegian pharmaceutical company Lytix Biopharma AS today announced approvals from the Norwegian Medicines Agency (”Statens legemiddelverk”) and the Swedish Medical Products Agency (”Läkemedelverket”) to commence Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer.

15 Dec 2009

Discrepancy in dance confidence between men and women due to genetic make-up

Men may shuffle on to the dance floor this Christmas, but once there, they will be impressed by their moves, according to research carried out by the 'Doctor of Dance' at the University of Hertfordshire.

15 Dec 2009

New study shows healthcare spending is an investment rather than an expenditure

As the national discussion of health care focuses on costs, a new study from North Carolina State University shows that it might be more accurate to think of health care spending as an investment that can spur economic growth.

15 Dec 2009

Bend Research makes available Type V DMF for HPMCAS concerning FDA regulatory filings

Bend Research Inc. announced today that its clients may now reference a key safety file for HPMCAS, an excipient used in technologies developed by the firm to enhance the oral bioavailability of clients' low-solubility drugs.

15 Dec 2009

Proposed national alcohol policies emphasise economic benefits of alcohol trade and positive health impacts

A recent comparison of proposed national alcohol policies in Lesotho, Malawi, Uganda, and Botswana shows that the drinks industry has assumed a significant and detrimental role in designing national alcohol policies in Sub-Saharan Africa.

15 Dec 2009

Teens, contraception and unplanned pregnancy

Nearly all unmarried young adults ages 18-29 believe pregnancy is something that should be planned (94% of men and 86% of women) and say that it is important to avoid pregnancy in their lives right now (86% of men and 88% of women), according to new research released by The National Campaign to Prevent Teen and Unplanned Pregnancy.

15 Dec 2009

Preventing tumours from making new blood vessels can also prevent spread of cancer

Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden. This discovery paves the way for new treatments for hormone-resistant prostate cancer.

15 Dec 2009

Alaska-Scientists identify a novel antifreeze molecule, xylomannan

Alaska-Scientists have identified a novel antifreeze molecule in a freeze-tolerant Alaska beetle able to survive temperatures below minus 100 degrees Fahrenheit. Unlike all previously described biological antifreezes that contain protein, this new molecule, called xylomannan, has little or no protein.

15 Dec 2009

REC releases social responsibility report on top global pharmaceutical companies

The Roberts Environmental Center (REC) at Claremont McKenna College today released the analysis of social responsibility reporting for the 26 largest pharmaceutical companies world-wide. The report contains a compilation of Pacific Sustainability Index (PSI) scores evaluating the environmental and social reporting of the companies.

15 Dec 2009

GBC: Most federal executives lack confidence in government on taking new roles in health care

According to a new study by Government Business Council (GBC), the research division of Government Executive Media Group, most federal executives lack confidence that the government can successfully take on new roles related to health care.

15 Dec 2009

Research News and Research

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Almac Discovery initiates Phase I clinical trial of intranasal Granisetron for CINV

Prescription drug import amendment divides Senate Democrats

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

University of Wisconsin IRB approves GenSpera's G-202 Phase I study for cancer

Encouraging results from DAVANAT in combination with chemotherapies and biologics

Celgene announces positive data from its apremilast Phase IIb study for plaque-type psoriasis

Interpersonal Psychotherapy may hold hope for teenager girls at risk of obesity

Cellular and subcellular effects of PACE technology presented

Lytix Biopharma AS receives approval to commence Phase I clinical trials of Oncopore

Discrepancy in dance confidence between men and women due to genetic make-up

New study shows healthcare spending is an investment rather than an expenditure

Bend Research makes available Type V DMF for HPMCAS concerning FDA regulatory filings

Proposed national alcohol policies emphasise economic benefits of alcohol trade and positive health impacts

Teens, contraception and unplanned pregnancy

Preventing tumours from making new blood vessels can also prevent spread of cancer

Alaska-Scientists identify a novel antifreeze molecule, xylomannan

REC releases social responsibility report on top global pharmaceutical companies

GBC: Most federal executives lack confidence in government on taking new roles in health care

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News